about
VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growthBrain tumor-targeted drug delivery strategiesMechanisms of tubulogenesis and endothelial phenotype expression by MSCsEscaping Antiangiogenic Therapy: Strategies Employed by Cancer CellsAdaptation to antiangiogenic therapy in neurological tumorsEpigenetic effects of cadmium in cancer: focus on melanomaRANK-mediated signaling network and cancer metastasis.Paris polyphylla Suppresses Proliferation and Vasculogenic Mimicry of Human Osteosarcoma Cells and Inhibits Tumor Growth In Vivo.Three-dimensional volume reconstruction of extracellular matrix proteins in uveal melanoma from fluorescent confocal laser scanning microscope imagesADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2.Comparing vasculogenic mimicry with endothelial cell-lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks.Modeling the behavior of uveal melanoma in the liver.The therapeutic promise of the cancer stem cell concept.A combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivoInhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway.Epithelial-mesenchymal transition regulated by EphA2 contributes to vasculogenic mimicry formation of head and neck squamous cell carcinoma.Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions.Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in GlioblastomaVasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma.Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapyAberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell linesNicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaA pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro.Understanding tumor heterogeneity as functional compartments--superorganisms revisited.Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factorsTumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas.Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets.Transforming growth factor-β is required for vasculogenic mimicry formation in glioma cell line U251MG.Dual effects of collagenase-3 on melanoma: metastasis promotion and disruption of vasculogenic mimicry.Linearly Patterned Programmed Cell Necrosis Induced by Chronic Hypoxia Plays a Role in Melanoma Angiogenesis.Vasculogenic mimicry is a major feature and novel predictor of poor prognosis in patients with orbital rhabdomyosarcoma.Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation.Pulmonary carcinoma with metastasis in a long-finned pilot whale (Globicephala melas).The effect of bevacizumab on human malignant melanoma cells with functional VEGF/VEGFR2 autocrine and intracrine signaling loops.Quantitative evaluation of viable tissue perfusion changes with contrast-enhanced greyscale ultrasound in a mouse hepatoma model following treatment with different doses of thalidomideInnovative therapeutic strategies in the treatment of brain metastases.Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma.
P2860
Q24606018-872C5250-F988-4462-846B-09A9C0827198Q26829741-0DA34D64-B26D-45A7-B2D1-3CEC80918583Q27308660-6FA54BAE-D107-4616-B114-560C6BB95030Q28067753-A2E18E1B-7887-45E0-A4E9-1C04DF278D07Q28082908-98FADBDE-2DDD-4846-9B2C-659B19721BD0Q28386972-8EC1ED54-8AB4-49F3-A30D-CAE0084031CFQ30371052-E1549393-2808-4346-A5AA-E26D313FE6A8Q32178720-4733A1E2-249E-45E9-A5C6-78CE1AC56FEAQ33232545-1A2B3219-76D1-4C22-885B-39B07927CB42Q33241217-E7B672C9-B61C-4DEC-AE4B-F25CD51EEDC3Q33286127-4FECF9FB-02C2-411F-8BB7-16871DA470AFQ33288794-C60709BC-3729-40CE-9F24-C190A390EB52Q33559711-A9BCEA63-16AD-4F16-911B-1D6E004FB013Q33576606-D14035B8-D4D2-4491-AC24-BAFD60B5BE9DQ33584252-165D91FF-2058-4A41-AAAE-706CC4AACA31Q33594147-F7EC13F2-320B-460B-B67F-85D8C7034F65Q33610570-AF4627A1-0FBF-4603-8A2F-FBAF10523CFCQ33770680-A3B0D878-4563-4903-838E-7711017CB5CAQ33868524-013DD7DD-AB15-44A4-9569-6F7285272607Q33921567-8FD2973F-8630-4DEC-96F9-1C0501604033Q34391376-3774D086-3170-46ED-A0E8-1167A39D1FEAQ34484134-6318D136-D925-4530-B6BE-774CA2DFB4D9Q34578831-16AA7EAD-FA30-4E69-B14A-118E41F4CD00Q34603154-F769DF6D-4B50-497E-9A39-22B81F7D4852Q34995053-7678A32A-0497-456E-8C5E-2595BC829E33Q35054645-7AD3BF02-0333-427E-9636-059EA7499DADQ35176196-631501CA-7DA2-4C20-9593-2A7A225E1AF2Q35222151-497DFF17-672D-43E5-AC48-EE51801F32B9Q35746801-691486FC-9F4B-4C62-A3B9-33FE960E6D02Q35748107-2D96B04B-F473-430B-A2BC-9905A0ED6B9AQ35760962-C02A17A1-B851-42E6-8FF7-CFB989C43D2CQ35832252-A8EFF915-0E9C-42D0-992D-79739FECCD80Q35882977-3114A573-307B-4646-AE60-5CE62678C131Q35943307-3FC8A17F-D8D7-4E81-BC87-293224266024Q36098121-F3B4DCDF-7E78-4B8A-9701-30BAEFD2638FQ36160864-109AFA99-9884-47DC-976D-61C7EA4E786AQ36172732-642A24A2-137B-44C9-85DC-0223638E34CDQ36324991-E7B19BBE-EFAA-4481-B7A4-C057236FA958Q36590195-087D2A73-E9B2-4114-A213-BE001922A8E9Q36614375-5C63C0A1-FB90-4888-BA4D-0721E4405105
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Vasculogenic mimicry.
@ast
Vasculogenic mimicry.
@en
Vasculogenic mimicry.
@nl
type
label
Vasculogenic mimicry.
@ast
Vasculogenic mimicry.
@en
Vasculogenic mimicry.
@nl
prefLabel
Vasculogenic mimicry.
@ast
Vasculogenic mimicry.
@en
Vasculogenic mimicry.
@nl
P2860
P1476
Vasculogenic mimicry.
@en
P2093
Andrew J Maniotis
Robert Folberg
P2860
P304
P356
10.1111/J.1600-0463.2004.APM11207-0810.X
P577
2004-07-01T00:00:00Z